磷酸化蛋白磷酸激酶PKC/CPI-17抗体

Quantity size:

0.1ml

Concentration:

1mg/ml磷酸化蛋白磷酸激酶PKC/CPI-17抗体   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The protein encoded by this gene belongs to the protein phosphatase 1 (PP1) inhibitor family. This protein is an inhibitor of smooth muscle myosin phosphatase, and has higher inhibitory activity when phosphorylated. Inhibition of myosin phosphatase leads to 磷酸化蛋白磷酸激酶PKC/CPI-17抗体increased myosin phosphorylation and enhanced smooth muscle contraction. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Sep 2011]

Also known as:

磷酸化蛋白磷酸激酶PKC/CPI-17抗体CPI17 alpha (phospho T38); p-CPI17 alpha (phospho T38); 17kDa PKC potentiated inhibitory protein of PP1; CPI 17 alpha; CPI 17; CPI 17alpha; CPI17; CPI-17; PKC potentiated inhibitory protein of PP1; PPP1INL; PPP1R14A; Protein phosphatase 1; Protein phosphatase 1 regulatory (inhibitor) subunit 14A; Protein phosphatase 1 regulatory subunit 14A; Regulatory subunit 14A; 17 kDa PKC-potentiated inhibitory protein of PP1; 17-KDa protein; 17kDa PKC potentiated inhibitory protein of PP1;磷酸化蛋白磷酸激酶PKC/CPI-17抗体 PKC potentiated inhibitory protein of PP1; PKC potentiated inhibitory protein of PP1, 17-KD; PP14A_HUMAN; Protein kinase C-potentiated inhibitor of protein phosphatase 1, 17-KD; Protein kinase C-potentiated inhibitor protein of 17 kDa; Protein phosphatase 1; Protein phosphatase 1 regulatory (inhibitor) subunit 14A; Regulatory subunit 14A.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human CPI17 alpha 磷酸化蛋白磷酸激酶PKC/CPI-17抗体around the phosphorylation site of Thr38.

●

Predicted Molecular Weight: 17kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl533Hu01细胞间粘附分子3(ICAM3)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 3 (ICAM3)

kl534Hu01细胞间粘附分子2(ICAM2)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 2 (ICAM2)

kl534Mu01细胞间粘附分子2(ICAM2)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 2 (ICAM2)

kl534Rb51细胞间粘附分子2(ICAM2)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 2 (ICAM2)

kl536Hu01亮氨酰氨基肽酶(LAP)多克隆抗体Polyclonal Antibody to Leucine Aminopeptidase (LAP)

kl536Ra01亮氨酰氨基肽酶(LAP)多克隆抗体Polyclonal Antibody to Leucine Aminopeptidase (LAP)

kl537Hu01神经元特异性烯醇化酶(NSE)多克隆抗体Polyclonal Antibody to Enolase, Neuron Specific (NSE)

kl537Mu01神经元特异性烯醇化酶(NSE)多克隆抗体Polyclonal Antibody to Enolase, Neuron Specific (NSE)

kl537Ra01神经元特异性烯醇化酶(NSE)多克隆抗体Polyclonal Antibody to Enolase, Neuron Specific (NSE)

kl547Hu01血管细胞粘附分子1(VCAM1)多克隆抗体Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)

kl547Mu01血管细胞粘附分子1(VCAM1)多克隆抗体Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)

kl547Ra01血管细胞粘附分子1(VCAM1)多克隆抗体Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)

kl547Rb52血管细胞粘附分子1(VCAM1)多克隆抗体Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)

kl547Si01血管细胞粘附分子1(VCAM1)多克隆抗体Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)

kl548Ca01细胞间粘附分子1(ICAM1)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 1 (ICAM1)

kl548Hu01细胞间粘附分子1(ICAM1)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 1 (ICAM1)

kl548Mu01细胞间粘附分子1(ICAM1)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 1 (ICAM1)

kl548Po01细胞间粘附分子1(ICAM1)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 1 (ICAM1)

kl548Ra01细胞间粘附分子1(ICAM1)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 1 (ICAM1)

kl548Rb51细胞间粘附分子1(ICAM1)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 1 (ICAM1)

kl549Hu01角蛋白9(KRT9)多克隆抗体Polyclonal Antibody to Keratin 9 (KRT9)